Evidence map›Paper›PMID 38250882›Full record

ArticleVaccines2024

No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort.

Deepak Nagra, Katie Bechman, Mark D Russell, Zijing Yang, Maryam Adas, Sujith Subesinghe, Andrew Rutherford, Edward Alveyn, Samir Patel, Chris Wincup and 6 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Deepak NagraCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.ORCID 0000-0002-1307-6528
Katie BechmanCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Mark D RussellCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Zijing YangCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Maryam AdasCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Sujith SubesingheCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Andrew RutherfordCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Edward AlveynCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Samir PatelCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Chris WincupKing's College Hospital NHS Trust, London SE5 9RS, UK.
Arti MahtoKing's College Hospital NHS Trust, London SE5 9RS, UK.
Christopher BaldwinCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Ioasaf KarafotiasCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.ORCID 0000-0003-2513-215X
Andrew CopeCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
Sam NortonCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
James GallowayCentre for Rheumatic Disease, King's College London, London WC2R 2LS, UK.
King's College London · GBKing's College Hospital · GB

Funding

Versus Arthritis 21992
6 · The paper itself

Abstract

backgroundVaccination against pneumococcus reduces the risk of infective events, hospitalisation, and death in individual with inflammatory arthritis, particularly in those on immunomodulating therapy who are at risk of worse outcomes from pneumococcal disease. The objective of this study was to investigate the serological protection following vaccination against pneumococcal serovars over time.

Indexed as

arthritisimmunosuppressionpneumococcal vaccinePPSV23

Identifiers

PMID38250882
PMCPMC10818273
OpenAlexW4390704796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.